A UK Biobank analysis is going viral as proof that sunscreen causes skin cancer. It is observational, its own author says the association reflects sun exposure, and the only randomized trial ever run found half as many melanomas with daily sunscreen.
In plain terms A very large study found that people who use sunscreen get more skin cancer. That is because people who burn easily or spend a lot of time in the sun use the most sunscreen. In the one study where people were randomly assigned to use sunscreen daily, they got half as many melanomas. Chemical filters do get into the blood, which is why the FDA is still collecting safety data, but no study has shown sunscreen causes cancer.
A 2023 paper in Cancer Epidemiology, Biomarkers and Prevention analyzed UK Biobank records from 472,672 adults: 24,508 with skin cancer diagnoses and 448,164 controls[1]. Its purpose was gene-environment analysis, how DNA repair variants interact with sun behavior. It was not designed to test whether sunscreen causes anything.
The paper reports that frequent sunscreen use tracked with higher recorded rates of all four skin cancer types, invasive melanoma RR 1.36 to 3.92 across usage frequencies[1]. Social posts have read that row as a causal finding.
There is a second, older layer to the claim: FDA trials showing chemical UV filters absorb into blood at levels above 0.5 ng/mL[5][6]. That absorption data is real, verified, and worth knowing. It is also not cancer evidence. Absorption triggers a request for more safety data. It does not demonstrate harm.
This is the pattern this site exists to police. A big number, a real paper, a causal verb the paper never used. Every element of the viral claim is real except the conclusion.
| Evidence | Type | Size | Window | What it showed |
|---|---|---|---|---|
| UK Biobank analysis (2023) | Observational, 472,672 adults | 472,672 | Snapshot | More sunscreen use tracked with more recorded skin cancer; authors attribute it to sun-exposure behavior, not sunscreen[1] |
| Nambour trial (2011) | Randomized controlled trial, Australia | 1,621 | 10 years post-trial | Half as many melanomas with daily sunscreen: 11 vs 22; invasive melanoma 3 vs 11[3] |
| FDA maximal-use trial (2019) | RCT, systemic absorption, maximal use | 24 | 7 days | All 4 chemical filters absorbed above 0.5 ng/mL; oxybenzone peaked at 169 to 210 ng/mL[5] |
| FDA maximal-use trial (2020) | RCT, systemic absorption, maximal use | 48 | 21 days | All 6 chemical filters above 0.5 ng/mL; levels persisted 7 to 21 days after last dose[6] |
| Valisure benzene tests (2021) | Independent lab, 294 batches | 294 batches | One-time | 78 of 294 batches contained benzene, 14 at 2.78 to 6.26 ppm; contaminant, not an ingredient[8] |
All references verified on September 18, 2026.
The UK Biobank records sunscreen use as a self-reported habit at enrollment. The skin cancer diagnoses came from national registries. Neither is assigned, randomized, or controlled. This is the weakest rung of the evidence ladder for causation questions, and the paper itself is a gene-environment analysis, not an intervention study[1].
The study's own discussion addresses the sunscreen numbers head on. The authors write that people who use sunscreen most are the people at highest risk, those with the highest sun exposure and those with prior skin cancer diagnoses. The senior author, Ivan Litvinov, has confirmed this in public: the association reflects a sunscreen paradox, where users spend more time in the sun, burn more, and carry a false sense of protection[2].
That is the authors' explanation, and it comes with its own caution: an observational explanation of an observational finding. What settles the question is a different kind of study, and one exists.
In 1992, 1,621 adults in Nambour, Australia, were randomly assigned to apply sunscreen daily or use it at their own discretion. Random assignment is the design that cuts through confounding: if the daily-sunscreen group then develops fewer melanomas, the sunscreen is the difference[3].
After 10 years of follow-up past the trial period, the daily-sunscreen group had 11 melanomas versus 22 in the control group, a 50% reduction (HR 0.50, 95% CI 0.24 to 1.02). Invasive melanoma fell 73%: 3 cases versus 11 (HR 0.27, 95% CI 0.08 to 0.97)[3].
A 2018 review in the British Journal of Dermatology examined the entire evidence base and keeps the caveat honest: this single trial is the best available evidence, melanoma was a secondary endpoint, and the case counts are small. There is no level-1 evidence for all melanomas combined, and no RCTs exist for clothing or shade either[4].
The honest summary runs: the strongest available human evidence points to protection. The certainty is moderate, not absolute. Neither statement supports the word causes.
Swipe the chart sideways
Two findings from the FDA deserve space in this conversation because they are real and verified. The 2019 and 2020 maximal-use trials showed all tested chemical filters absorb above the 0.5 ng/mL plasma threshold on day 1 of use, and two filters, homosalate and oxybenzone, stayed above it for 21 days after the last application[5][6].
Context for that number: 0.5 ng/mL is not a safety line. It is the FDA threshold above which manufacturers must submit additional toxicology data, including carcinogenicity testing. The FDA's own trials, which generated the finding, state the results do not mean people should stop using sunscreen[6].
The benzene findings are separate. In 2021, the independent lab Valisure detected benzene in 78 of 294 tested sunscreen batches, 14 of them between 2.78 and 6.26 ppm. Johnson & Johnson recalled five aerosol lines as a result[8][9].
The benzene case is the closest the sunscreen story comes to a genuine carcinogen, and it is a manufacturing-contamination story, not an ingredient story. Benzene was never part of any formula. It appeared in specific lots of specific aerosol products. 217 of the 294 tested batches contained none at all[8].
The regulatory consequence is also real: the FDA recognizes only zinc oxide and titanium dioxide, the two mineral filters, as GRASE, generally recognized as safe and effective. Twelve chemical filters, including oxybenzone, avobenzone, octocrylene and octinoxate, are held in an insufficient-data category pending industry studies[7].
Swipe the chart sideways
The strongest version of the viral posts, the one with the most truth per sentence, reads: chemical filters absorb, several still need safety data, mineral filters do not. That is a fair compression of the FDA record[7].
But note what it does not say. It does not say chemical filters cause cancer, because no study shows that. It does not say mineral filters work better at preventing cancer, because no comparative trial exists. And it does not remove the primary variable, which is the sun itself.
Practical conclusion for a consumer who wants the smallest exposure profile: a zinc oxide or titanium dioxide sunscreen, SPF 30 or higher, reapplied at the labeled interval, combined with shade and clothing for long exposures. The UK Biobank data does not argue against that. It argues for it[2].
The one behavior the viral posts get right is the one dermatology has pushed for decades: do not use sunscreen as a license to stay in the sun longer. That is the false sense of protection the Nambour researchers and the UK Biobank authors both describe. The failure mode of sunscreen is under-application and over-exposure, not the bottle.
Grounds: Nambour RCT, 1,621 adults
Invasive melanoma: 73% fewer
The one randomized trial ran in exactly this population: subtropical Queensland adults with outdoor exposure. Daily users developed half as many melanomas.
Grade B evidenceRead the Nambour follow-upGRASE status: only 2 filters of 16
Absorption: minimal through skin
The FDA recognizes only zinc oxide and titanium dioxide as GRASE at up to 25%. Twelve chemical filters carry an insufficient-data flag pending industry studies, and 2 of the 6 FDA-tested filters stayed in plasma for 21 days.
Regulator-recognizedRead the FDA proposed ruleDesign: observational, 472,672 adults
Author's take: sun-exposure confounding
Observational data cannot separate sunscreen from sun. The study's own senior author says the pattern reflects high-risk people using more sunscreen, and that proper use reduces skin cancer risk.
Not causal evidenceRead the Reuters fact checkFound: 78 of 294 batches, max 6.26 ppm
Response: 5 aerosol lines recalled
Benzene was never a sunscreen ingredient. It was a manufacturing contaminant in specific aerosol lots. 217 of 294 tested batches showed none.
Contamination, not causationRead the recall noticeThe FDA recognizes exactly two sunscreen filters as GRASE. The absorption data argues for mineral filters, not against sunscreen.
No human study has shown a causal link. The claim usually traces to a 2023 observational UK Biobank analysis that found more sunscreen use tracking with more recorded skin cancer. The study's senior author has stated publicly that the pattern reflects sun-exposure behavior: people who use sunscreen spend more time in the sun, burn more, and feel falsely protected. The only randomized trial with melanoma endpoints, the Nambour trial, found fewer melanomas in the daily-sunscreen group.
Confounding. Sunscreen use correlates with fair skin, sun-heavy lifestyles, and prior skin cancer diagnoses, the exact factors that raise skin cancer risk. A snapshot study cannot separate the sunscreen from the sun. Randomized assignment is the only design that can, and it pointed the other way.
Yes. FDA maximal-use trials showed all six tested chemical filters exceeded the 0.5 ng/mL plasma threshold on day 1, and two stayed above it for 21 days after the last application. The 0.5 ng/mL line is not a safety limit. It is the level above which the FDA requires additional toxicology data. The FDA states these findings do not mean people should stop using sunscreen.
Yes, in 2021, as a contaminant. The independent lab Valisure detected benzene in 78 of 294 tested batches, with 14 lots between 2.78 and 6.26 ppm. Johnson & Johnson recalled five aerosol lines. Benzene was not an ingredient in any formula. It was a manufacturing contaminant, and 217 of 294 batches contained none.
Not meaningfully in real-world use. The worry is reasonable in theory: UVB drives vitamin D synthesis and sunscreen blocks UVB. But trials that measured vitamin D while people used sunscreen found no clinically relevant deficiency at typical application. The dose-response curve saturates, brief midday exposure produces most of the day's vitamin D, and users under-apply.
Corrections and source queries: info@no1gevity.com.